Reversible Protein Acetylation (eBook, PDF)
Redaktion: Bock, Gregory R.; Goode, Jamie A.
161,99 €
161,99 €
inkl. MwSt.
Sofort per Download lieferbar
0 °P sammeln
161,99 €
Als Download kaufen
161,99 €
inkl. MwSt.
Sofort per Download lieferbar
0 °P sammeln
Jetzt verschenken
Alle Infos zum eBook verschenken
161,99 €
inkl. MwSt.
Sofort per Download lieferbar
Alle Infos zum eBook verschenken
0 °P sammeln
Reversible Protein Acetylation (eBook, PDF)
Redaktion: Bock, Gregory R.; Goode, Jamie A.
- Format: PDF
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei
bücher.de, um das eBook-Abo tolino select nutzen zu können.
Hier können Sie sich einloggen
Hier können Sie sich einloggen
Sie sind bereits eingeloggt. Klicken Sie auf 2. tolino select Abo, um fortzufahren.
Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei bücher.de, um das eBook-Abo tolino select nutzen zu können.
A comprehensive review of recent work on chromatin and non-histone proteins, this book arises from the interactions of a multidisciplinary group of scientists involved in the study of acetylation. This area of research opens up new and exciting possibilities for drug design, and so the final chapters in the book examine some of the potential applications in the treatment of various diseases.
- Geräte: PC
- mit Kopierschutz
- eBook Hilfe
- Größe: 3.82MB
Andere Kunden interessierten sich auch für
- The Septins (eBook, PDF)149,99 €
- Lorenzo A. PinnaProtein Kinase CK2 (eBook, PDF)183,99 €
- Georges VauquelinG Protein-coupled Receptors (eBook, PDF)144,99 €
- Analysing Gene Expression (eBook, PDF)279,99 €
- Protein Microarray Technology (eBook, PDF)117,99 €
- Novel Therapeutic Proteins (eBook, PDF)142,99 €
- Protein Misfolding, Aggregation and Conformational Diseases (eBook, PDF)161,95 €
-
-
-
A comprehensive review of recent work on chromatin and non-histone proteins, this book arises from the interactions of a multidisciplinary group of scientists involved in the study of acetylation. This area of research opens up new and exciting possibilities for drug design, and so the final chapters in the book examine some of the potential applications in the treatment of various diseases.
Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.
Produktdetails
- Produktdetails
- Verlag: John Wiley & Sons
- Seitenzahl: 310
- Erscheinungstermin: 2. Juni 2004
- Englisch
- ISBN-13: 9780470862629
- Artikelnr.: 37299549
- Verlag: John Wiley & Sons
- Seitenzahl: 310
- Erscheinungstermin: 2. Juni 2004
- Englisch
- ISBN-13: 9780470862629
- Artikelnr.: 37299549
- Herstellerkennzeichnung Die Herstellerinformationen sind derzeit nicht verfügbar.
The Novartis Foundation is an international scientific and educational charity which promotes the study and general knowledge of science and in particular encourages international co-operation in scientific research.
Chair's Introduction (E. Verdin).
Beyond the double helix: writing and reading the histone code (Y. Wang, et
al.).
The indexing potential of histone lysine methylation (G. Schotta, et al.)
A model for step-wise assembly of heterochromatin in yeast (D. Moazed, et
al.).
H2B Ubiquitylation and deubiquitylation in gene activation (A. Wyce, et
al.).
Structural and chemical basis of histone acetylation (R. Marmorstein).
Phosphorylation and acetylation of histone H3 at inducible genes: two
controversies revisted (L. Mahadevan, et al.).
HDAC7 regulates apoptosis in developing thymocytes (E. Verdin, et al.).
Dual roles of histone deacetylases in the control of cardiac growth (T.
McKinsey and E. Olson).
Chromatin modifications as clues to the regulation of antigen receptor
assembly (D. Ciccone and M. Oettinger).
General discussion I Histone modifications in X inactivation.
The HDAC complex and cytoskeleton (J. Kovacs, et al.).
Tat acetylation: a regulatory switch between early and late phases in HIV
transcription elongation (M. Ott, et al.).
Dynamics of the p53 acetylation pathway (W. Gu, et al.).
Regulation of the NF-kB action by reversible acetylation (W. Greene and L.
Chen).
General discussion II p300 and DNA repair.
Reversal of gene silencing as a therapeutic target for cancer - roles for
DNA methylation and interdigitation with chromatin (S. Baylin).
Transcription regulation by histone deacetylases (S. Wang, et al.).
Molecular and cellular basis for the anti-proliferative effects of the HDAC
inhibitor LAQ824 (P. Atadja, et al.).
Histone deacetylase inhibitors: development as cancer therapy (P. Marks, et
al.).
General discussion III PML-RAR hypermethylation in leukemia.
Index of Contributors.
Subject Index.
Beyond the double helix: writing and reading the histone code (Y. Wang, et
al.).
The indexing potential of histone lysine methylation (G. Schotta, et al.)
A model for step-wise assembly of heterochromatin in yeast (D. Moazed, et
al.).
H2B Ubiquitylation and deubiquitylation in gene activation (A. Wyce, et
al.).
Structural and chemical basis of histone acetylation (R. Marmorstein).
Phosphorylation and acetylation of histone H3 at inducible genes: two
controversies revisted (L. Mahadevan, et al.).
HDAC7 regulates apoptosis in developing thymocytes (E. Verdin, et al.).
Dual roles of histone deacetylases in the control of cardiac growth (T.
McKinsey and E. Olson).
Chromatin modifications as clues to the regulation of antigen receptor
assembly (D. Ciccone and M. Oettinger).
General discussion I Histone modifications in X inactivation.
The HDAC complex and cytoskeleton (J. Kovacs, et al.).
Tat acetylation: a regulatory switch between early and late phases in HIV
transcription elongation (M. Ott, et al.).
Dynamics of the p53 acetylation pathway (W. Gu, et al.).
Regulation of the NF-kB action by reversible acetylation (W. Greene and L.
Chen).
General discussion II p300 and DNA repair.
Reversal of gene silencing as a therapeutic target for cancer - roles for
DNA methylation and interdigitation with chromatin (S. Baylin).
Transcription regulation by histone deacetylases (S. Wang, et al.).
Molecular and cellular basis for the anti-proliferative effects of the HDAC
inhibitor LAQ824 (P. Atadja, et al.).
Histone deacetylase inhibitors: development as cancer therapy (P. Marks, et
al.).
General discussion III PML-RAR hypermethylation in leukemia.
Index of Contributors.
Subject Index.
Chair's Introduction (E. Verdin).
Beyond the double helix: writing and reading the histone code (Y. Wang, et
al.).
The indexing potential of histone lysine methylation (G. Schotta, et al.)
A model for step-wise assembly of heterochromatin in yeast (D. Moazed, et
al.).
H2B Ubiquitylation and deubiquitylation in gene activation (A. Wyce, et
al.).
Structural and chemical basis of histone acetylation (R. Marmorstein).
Phosphorylation and acetylation of histone H3 at inducible genes: two
controversies revisted (L. Mahadevan, et al.).
HDAC7 regulates apoptosis in developing thymocytes (E. Verdin, et al.).
Dual roles of histone deacetylases in the control of cardiac growth (T.
McKinsey and E. Olson).
Chromatin modifications as clues to the regulation of antigen receptor
assembly (D. Ciccone and M. Oettinger).
General discussion I Histone modifications in X inactivation.
The HDAC complex and cytoskeleton (J. Kovacs, et al.).
Tat acetylation: a regulatory switch between early and late phases in HIV
transcription elongation (M. Ott, et al.).
Dynamics of the p53 acetylation pathway (W. Gu, et al.).
Regulation of the NF-kB action by reversible acetylation (W. Greene and L.
Chen).
General discussion II p300 and DNA repair.
Reversal of gene silencing as a therapeutic target for cancer - roles for
DNA methylation and interdigitation with chromatin (S. Baylin).
Transcription regulation by histone deacetylases (S. Wang, et al.).
Molecular and cellular basis for the anti-proliferative effects of the HDAC
inhibitor LAQ824 (P. Atadja, et al.).
Histone deacetylase inhibitors: development as cancer therapy (P. Marks, et
al.).
General discussion III PML-RAR hypermethylation in leukemia.
Index of Contributors.
Subject Index.
Beyond the double helix: writing and reading the histone code (Y. Wang, et
al.).
The indexing potential of histone lysine methylation (G. Schotta, et al.)
A model for step-wise assembly of heterochromatin in yeast (D. Moazed, et
al.).
H2B Ubiquitylation and deubiquitylation in gene activation (A. Wyce, et
al.).
Structural and chemical basis of histone acetylation (R. Marmorstein).
Phosphorylation and acetylation of histone H3 at inducible genes: two
controversies revisted (L. Mahadevan, et al.).
HDAC7 regulates apoptosis in developing thymocytes (E. Verdin, et al.).
Dual roles of histone deacetylases in the control of cardiac growth (T.
McKinsey and E. Olson).
Chromatin modifications as clues to the regulation of antigen receptor
assembly (D. Ciccone and M. Oettinger).
General discussion I Histone modifications in X inactivation.
The HDAC complex and cytoskeleton (J. Kovacs, et al.).
Tat acetylation: a regulatory switch between early and late phases in HIV
transcription elongation (M. Ott, et al.).
Dynamics of the p53 acetylation pathway (W. Gu, et al.).
Regulation of the NF-kB action by reversible acetylation (W. Greene and L.
Chen).
General discussion II p300 and DNA repair.
Reversal of gene silencing as a therapeutic target for cancer - roles for
DNA methylation and interdigitation with chromatin (S. Baylin).
Transcription regulation by histone deacetylases (S. Wang, et al.).
Molecular and cellular basis for the anti-proliferative effects of the HDAC
inhibitor LAQ824 (P. Atadja, et al.).
Histone deacetylase inhibitors: development as cancer therapy (P. Marks, et
al.).
General discussion III PML-RAR hypermethylation in leukemia.
Index of Contributors.
Subject Index.